Current hospital tests for the bacterium Clostridium difficile (C. difficile) are not accurate enough and a new two-stage process should be introduced to avoid misdiagnosis and its consequences. These ...

After the first year of interventions at Emory Saint Joseph's Hospital, there was a 63% decrease in hospital-onset C. diff cases as compared to the two years prior. Through a series of interventions ...

Most laboratories have begun using polymerase chain reaction assays, or the PCR technique, as opposed to enzyme-linked immunosorbent assay detection, also known as ELISA testing, to diagnose ...

Arlington, Va. — June 27, 2024 — A new study published today in the American Journal of Infection Control (AJIC) describes the outcome of a new approach to testing for Clostridioides difficile (C.

After piloting new Clostridioides difficile guidelines for nine months, Memorial Healthcare System reduced unnecessary treatments by 20.1%, according to a study published June 27 in the American ...

The bacterium Clostridioides difficile, which was formerly named Clostridium difficile and is now commonly known as C. difficile or simply C. diff, is a common microorganism found in the environment.

This study explores the effectiveness of toxin testing in predicting Clostridioides difficile infection (CDI) outcomes, revealing that patients with negative toxin results were less likely to ...

ILC 2023 FMT Modifies Gut Microbiome, Reduces Ammonia in Cirrhosis Fecal microbiota transplant (FMT) promotes restoration of the gut microbiota, enzymes, and immune responses, and reduces ammonia ...

C. diff colitis is inflammation of a person’s colon due to contagious bacteria. Most people with C. diff colitis fully recover, but in rare cases the condition can be life threatening. It is possible ...